| Literature DB >> 22188643 |
Anesh Nair1, Haralambos Korres, Naresh K Verma.
Abstract
BACKGROUND: The three bacteriophage genes gtrA, gtrB and gtr((type)) are responsible for O-antigen glucosylation in Shigella flexneri. Both gtrA and gtrB have been demonstrated to be highly conserved and interchangeable among serotypes while gtr((type)) was found to be specific to each serotype, leading to the hypothesis that the Gtr((type)) proteins are responsible for attaching glucosyl groups to the O-antigen in a site- and serotype- specific manner. Based on the confirmed topologies of GtrI, GtrII and GtrV, such interaction and attachment of the glucosyl groups to the O-antigen has been postulated to occur in the periplasm.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22188643 PMCID: PMC3259042 DOI: 10.1186/1471-2091-12-67
Source DB: PubMed Journal: BMC Biochem ISSN: 1471-2091 Impact factor: 4.059
Analysis of gtrIV-phoA/lacZ fusions and gtrIV-phoA/lacZ-gtrIV sandwich fusions for GtrIV topology determination
| Sample ID | AA1 | Colour2 | Average AP3 | Average BG4 | %AP5 | %BG6 | NAR7 | Location on Model8 |
|---|---|---|---|---|---|---|---|---|
| B1925 | A15 | Purple | 311 ± 9 | 25 ± 2 | 32.6% | 16.1% | 2:1 | t.1 |
| B1910 | N29 | Blue | 356 ± 47 | 1# | 37.3% | 0.6% | 52:1 | p.2 |
| B1924 | P38 | Blue | 357 ± 44 | 2# | 37.5% | 1.3% | 24:1 | p.2 |
| B1907 | N41 | Blue | 296 ± 47 | 1# | 31.1% | 0.6% | 38:1 | p.2 |
| B1935 | G42 | Blue | 195 ± 28 | 3 ± 1 | 20.5% | 1.3% | 20:1 | p.2 |
| B1906 | L56 | Blue | 133 ± 29 | 4 ± 1 | 14.0% | 2.6% | 5:1 | p.2 |
| B1931 | F60 | Blue | 383 ± 25 | 1# | 40.2% | 0.6% | 57:1 | p.2 |
| B1912 | Q186 | Purple | 9 ± 91 | 15 ± 2 | 0.9% | 9.7% | 1:11 | t.4 |
| B1919 | I200 | Red | 22 ± 4 | 132 ± 6 | 2.3% | 85.1% | 1:34 | t.4 |
| B1913 | N235 | Blue | 292 ± 51 | 0# | 30.6% | 0.0% | > 100:1 | p.6 |
| B1926 | L240 | Blue | 394 ± 20 | 1# | 41.4% | 0.7% | 58:1 | p.6 |
| B1904 | L246 | Blue | 660 ± 39 | 1# | 69.3% | 0.7% | 97:1 | p.6 |
| B1921 | N251 | Blue | 962* ± 59 | 1# | 100.9% | 0.9% | > 100:1 | p.6 |
| B1922 | N255 | Blue | 553 ± 30 | 0# | 58.1% | 0.1% | > 100:1 | p.6 |
| B1908 | D261 | Blue | 385 ± 55 | 2# | 40.4% | 1.2% | 33:1 | p.6 |
| B1905 | S300 | Blue | 426 ± 21 | 4 ± 1 | 43.6% | 2.8% | 16:1 | p.6 |
| B1923 | M310 | Blue | 589 ± 15 | 1 ± 1 | 61.8% | 0.1% | > 100:1 | p.6 |
| B1920 | V359 | Purple | 269 ± 34 | 9 ± 1 | 28.2% | 5.5% | 5:1 | t.6 |
| B1911 | Q393 | Purple | 12 ± 3 | 8 ± 2 | 1.2% | 4.9% | 1:4 | t.7 |
| B2216 | V102 | Red | 2# | 121 ± 17 | 0.2% | 78.2% | 1: > 100 | c.3 |
| B1937 | D146 | Blue | 953 ± 35 | 7 ± 1 | 100.0% | 4.3% | 23:1 | re (p.4) |
| B2217 | V155 | Red | 6 ± 2 | 71 ± 9 | 0.6% | 45.8% | 1:76 | re (c.4) |
| B2405 | K162 | Red | 5# | 11# | 0.5% | 7.1% | 1:14 | re (c.4) |
| B2225 | D169 | Red | 3# | 79 ± 17 | 0.3% | 51.1% | 1: > 100 | re (c.4) |
| B1936 | D406 | Blue | 177 ± 40 | 1# | 18.6% | 0.9% | 20:1 | p.8 |
| B1914 | K437 | Red | 5 ± 1 | 155** ± 8 | 0.5% | 100.0% | 1: > 100 | c.9 |
| B2187 | R93 | Red | 0# | 10 ± 2 | 0.1% | 21.3% | 1: > 100 | c.3 |
| B2190 | K117 | Red | 0# | 14 ± 2 | 0.3% | 29.4% | 1: > 100 | c.3 |
| B2143 | A181 | Blue | 135+ ± 25 | 0# | 100.0% | 0.3% | > 100:1 | re (p.4) |
| B2192 | R375 | Red | 1 ± 1 | 47++ ± 7 | 0.4% | 100.0% | 1: > 100 | c.7 |
1 Position of the last residue of GtrIV followed by phoA/lacZ, 2 Colour of colony as seen on dual indicator plates, 3,4 Activities of the fusions, average of four independent experiments with standard deviations of each activity, 5,6 Percentages of AP and BG activities measured relative to the maximum activity in the set, 7Normalised AP:BG activity ratio (NAR) rounded to the nearest integer. 8Location of the fusion on the adjusted topological model of GtrIV(Figure 1); c, cytoplasm; p, periplasm; t, transmembrane helix; re, re-entrant loop. *Highest truncation AP, **Highest truncation BG, +Highest Sandwich fusion AP, ++Highest sandwich fusion BG. Since the random C-terminal fusions and PCR mediated fusions brought about truncated protein fused to the dual reporter, they were taken as one data set and the highest respective AP and BG values between them was used to calculate the NAR values. The NAR values for the sandwich fusions were calculated separately based on the highest AP and BG values obtained from all the sandwich fusions alone. #Standard deviations were less than 0.5 and not included.
Figure 1The final GtrIV topology model. Final GtrIV topology model after the creation of gtrIV-phoA/lacZ fusions by the Exo III deletion and PCR-based approaches, and gtrIV-phoA/lacZ-gtrIV sandwich fusions. In this model, GtrIV is shown to have 8 transmembrane helices and two large periplasmic loops. All Exo III mediated fusions are indicated with the closed circles while PCR mediated fusions are indicated with the crosses. All sandwich fusions are indicated with the stars. Blue coloured stars, circles and crosses depict fusions that have high PhoA NARs and appear blue on DI plates. Similarly, the ones in red depict fusions that have high LacZ NARs and appear red on DI plates. All purple fusions are seen to have occurred within transmembrane helices. The proposed re-entrant loop which traverses the plasma membrane from the periplasm into the cytoplasm, forming a cytoplasmic loop, occurs between transmembrane helices III and IV. All fusions have been labelled with the residue at which the fusion with PhoA/LacZ takes place or, in the case of sandwich fusions, where the dual reporter protein has been inserted.
Figure 2Model of GtrIV with all residues shown. Residues in pink are the 15 negatively charged amino acids present in loop No. 6. There are three negatively charged amino acid pairs DE261, ED283 and ED326. Deletion experiments for loop No. 2 involved deleting all the residues highlighted in brown, while a deletion in loop No. 3 was brought about by deleting all the residues highlighted in red. In loop No. 6, 4 different loop deletions were created. To investigate the importance of the negatively charged residues, all residues between the two black lines, which include all 15 negatively charged amino acids were deleted. To further investigate which sets of negatively charged residues were important, amino acids highlighted in green (loop No. 6 partial deletion 3), blue (loop No. 6 partial deletion 2) and orange (loop No. 6 partial deletion 1) were deleted separately.
Figure 3Functional analysis of deletion constructs. a) LPS Western blots and slide agglutination results. Deletion constructs were transformed into a serotype Y strain (SFL1616) to test for modification of O-antigen to serotype 4a. SFL 2324 is GtrIV fused to PhoA/LacZ and then transformed into SFL1616. The bright band is indicative of the serotype conversion from serotype Y to serotype 4a. The rest of the deletions show absence of modification to serotype 4a when probed with Type IV antisera. Results of the slide agglutination assays are indicated below the Western blots. A score of +ve indicates a positive result while a score of -ve indicates a negative result. b) Western blots (using anti-alkaline phosphatase primary antibody) performed on the membrane protein extractions of the various GtrIV loop deletion constructs that were fused to alkaline phosphatase. B2347 and B2348 were not detected, indicating GtrIV Loop No. 2 and Loop No. 3 deletions have a direct effect on the assembly of the protein in the cellular membrane. B2349, B2350 and B2352 were detected in lower amounts, the amount of protein that is assembled in the cellular membrane in these three deletion mutants is much lower as compared to the fully intact protein (B2339). The intense band seen for B2351 is almost the same as the fully intact protein.
Figure 4Further deletions of GtrIV loop No. 6. a) The sequence of the 19 amino acids located in GtrIV loop No. 6, which were targeted for further deletion. The dashes in the sequences of GtrIV FD1, FD2, FD3 and FD4 indicate the amino acids that were deleted in each deletion set. Amino acid numbers corresponding to the start and end of the peptide sequence are given below their respective residue. b) LPS Western blots of GtrIV deletion constructs that were transformed into SFL1616 (Serotype Y). Deletion constructs FD1(SFL2331) and FD2 (SFL2332) were able to convert serotype Y to serotype 4a, thus indicating functionality. The absence of bands for FD3 and FD4 indicates loss of function for these deletion mutants. c) Western blots of GtrIV Loop No. 6 further deletion constructs. All the further deletion constructs were detected when the membrane extracts were probed with anti-alkaline phosphatase. This indicated that the deletion proteins (which are fused to PhoA/LacZ) are expressed.
Predicted structures of the four chimeric proteins created in this study between GtrIc and GtrIV
| LPS | Membrane | ||||
|---|---|---|---|---|---|
| MASF Ic | Type IV | MASF Ic | Type IV | Anti-PhoA | |
| +ve | -ve | +ve | -ve | +ve | |
| -ve | +ve | -ve | +ve | +ve | |
| -ve | -ve | -ve | -ve | -ve | |
| -ve | -ve | -ve | -ve | +ve | |
| -ve | -ve | -ve | -ve | +ve | |
| -ve | -ve | -ve | -ve | +ve | |
Points of fusion: a) GtrIc-GtrIV loop No.2-GtrIc chimera:GtrIc-F31/GtrIV-N27, GtrIV-Y68/GtrIc-V100, b) GtrIV-GtrIc loop No.2-GtrIV chimera: GtrIV-M26/GtrIc-H32, GtrIc-N99/GtrIV-S71, c) GtrIc-GtrIV loop No.6-GtrIc chimera: GtrIc-P382/GtrIV-T231, GtrIV-K351/GtrIc-V495, d) GtrIV-GtrIc loop No.10-GtrIV chimera: GtrIV-S229/GtrIc-T231, GtrIc-V381/GtrIV-D352. To test for GtrIc function, the chimera constructs were transformed in to SFL1416 (Serotype 1a) to test for serotype conversion to serotype 1c using MASF Ic. As for GtrIV function, conversion to serotype 4a was tested by using Type IV antisera against constructs that were transformed into SFL1616 (serotype Y). All membrane protein westerns were carried using anti-alkaline phosphatse antibodies.